America’s fisheries are among the world’s richest in abundance and diversity. They provide scientific, aesthetic, recreational, commercial, subsistence, cultural, social, and economic benefits. FAC leads aquatic resource management for the Service and strives to invest its resources in the nation’s highest priority aquatic conservation and water-based recreational needs. Fish health is a critical component of healthy fisheries and core to the work of the Fish and Aquatic Conservation Program.
The Aquatic Animal Drug Approval Partnership (AADAP) program is part of the Fish and Aquatic Conservation fish health work. It is the only program in the United States singularly dedicated to obtaining U.S. Food and Drug Administration (FDA) approval of new medications needed for use in fish culture and fisheries management. Since the late 1990’s, AADAP has contributed to virtually every new fish medication approved by the FDA. Ultimately, the AADAP program allows fisheries professionals to more effectively and efficiently rear and manage a variety of fish species to meet production goals, stock healthy fish, and maintain a healthy environment.
Information to inform decisions regarding which medication to use, and how to use it. Safe, effective medications for treating fish diseases and managing fisheries—as well as informing the professionals who administer these medications—are growing needs.More
Investigational New Animal Drugs (INADs) are available through the National INAD Program (NIP) and can be used as long as study parameters are met and work is being done to reach full drug approval.More
Researchers use sound science to evaluate the safety and effectiveness of experimental fish medications. Results support FDA approval of the medications.More
Looking for an excuse to visit Bozeman, Montana this summer? Then mark your calendars for June 18 - 22 to attend the 24th Annual U.S. Fish and Wildlife Service, Aquaculture Drug Approval Coordination Workshop being held in conjunction with the 59th Annual Western Fish Disease Workshop.
Many of us may not be familiar with what it takes to get an animal drug approved with the FDA/CVM. You may have used an INAD for many years and you know it is safe and effective for your fish. But did you know that there are several other pieces of the packet that need to be completed before FDA/CVM can approve that drug? Let's break it down to see how an animal drug makes the journey from being an idea to a product on the market.
Don't miss out on the next issue of the AADAP Update. The Update is a monthly publication providing recent news and updates from the Aquatic Animal Drug Approval Partnership program and its partners. Please email to subscribe.